Skip to search formSkip to main contentSkip to account menu

bamipine

Known as: 1-methyl-N-phenyl-N-(phenylmethyl)-4-piperidinamine, 4-(N-Benzyl-N-phenylamino)-1-methylpiperidine, N-Phenyl-N-benzyl-4-amino-1-methyl-piperidine 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Histamine AntagonistsPiperidines

Narrower (1)

Soventol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Hybrid approach for the design of highly affine and selective dopamine D(3) receptor ligands using privileged scaffolds of biogenic amine GPCR ligands.
2005
2005
Hemmung der Erythrocyten-Sedimentation und -Aggregation in vitro durch verschiedene Substanzen
ZusammenfassungEine Anzahl von Pyrimidopyrimidin-Derivaten, die vorausgegangenen Befunden zufolge die Phosphat-, Monosaccharid… 
1990
1990
Activity of various amphiphilic agents in reversing multidrug resistance of L 1210 cells.
1987
1987
[Biotransformation and pharmacokinetics of bamipine in rats. 2. Pharmacokinetics (P 2)].
After oral application pharmacokinetic parameters of N-phenyl-N-benzyl-4-amino-1-methylpiperidin (bamipine) were investigated… 
1986
1986
Simultaneous determination of bromochlorosalicylanilide and bamipine in pharmaceutical formulations by high-performance liquid chromatography.
1978
1978
[Central and peripheral interactions of the antiparkinson agent biperiden and the antihistaminic bamipin on the rat excited by pilocarpine].
Excitatory reactions elicited by pilocarpine HCl (50 mg/kg i.v. in 6 s) are used for demonstrating synergistic effects of the… 
1963
1963
The value of biperiden alone and in combination with bamipine in the treatment of Parkinson's disease.
1963
1963
The value of biperiden alone and in combination with bamipine in the treatment of Parkinson's disease.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License